SRP5242
ERK5，活性，GST 标记 人
PRECISIO® Kinase, recombinant, expressed in baculovirus infected Sf9 cells, ≥70% (SDS-PAGE), buffered aqueous glycerol solution
别名:
BMK1, ERK4, MAPK7, PRKM7
登录 查看组织和合同定价。
选择尺寸
关于此项目
Specific activity:
9.4-12.7 nmol/min·mg
Assay:
≥70% (SDS-PAGE)
Biological source:
human
Recombinant:
expressed in baculovirus infected Sf9 cells
biological source
human
recombinant
expressed in baculovirus infected Sf9 cells
product line
PRECISIO® Kinase
assay
≥70% (SDS-PAGE)
form
buffered aqueous glycerol solution
specific activity
9.4-12.7 nmol/min·mg
mol wt
~132 kDa
NCBI accession no.
application(s)
cell analysis
shipped in
dry ice
storage temp.
−70°C
Gene Information
human ... MAPK7(5598)
Physical form
Supplied in 50mM Tris-HCl, pH 7.5, 150mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM DTT, 0.1mM PMSF, 25% glycerol.
Preparation Note
after opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles
Legal Information
PRECISIO is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
ERK5 Mediated Signalling in Diabetic Retinopathy
Yuexiu Wu
Medical Hypotheses (2015)
MAPK7 gene controls proliferation, migration and cell invasion in osteosarcoma.
Tesser-Gamba F
Molecular Carcinogenesis (2016)
C1q-TNF-related protein-9 promotes cardiac hypertrophy and failure
Mahesh Appari
Circulation Research (2016)
Role of MAPK7 in cell proliferation and metastasis in ovarian cancer
Jinhua D
International Journal of Clinical and Experimental Pathology (2015)
Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma
Paul R. Gavine
BMC Cancer (2015)
相关内容
Instructions
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持